Mass General Cancer Center — Boston, Massachusetts

Mass General Cancer Center is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Mass General Cancer Center has participated in 9 clinical trials with 6 currently active.

Therapeutic areas: Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer, NSCLC.

Sponsors: Incendia Therapeutics, Bayer, Sutro Biopharma, Inc..

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mass General Cancer Center?

Mass General Cancer Center has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mass General Cancer Center conducted?

Mass General Cancer Center has 9 clinical trials on record, with 6 currently active. Their work covers Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer, NSCLC.

Is Mass General Cancer Center accredited by Crixeo Health?

Yes — Mass General Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Mass General Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.